Diabetes, Endocrine System Diseases, Glucose Metabolism Disorders, Metabolic Diseases
Conditions
Keywords
diabetes,peer support
Brief summary
The prevalence of diabetes has been growing rapidly in developing countries causing a devastating economic burden and increasing demands on healthcare systems. Therefore, there is an urgent need to find cost-effective and multi-faceted approach for diabetes care. Peer support models provide a potentially low-cost, flexible means that is complimentary to the current existing health care services. Trained peer leaders can become qualified extenders to a formal healthcare system, thereby, assisting with the education delivery and bolstering the efforts of the professional staff. To implement a culturally- specific peer support program and determine whether it is acceptable, cost-effective in China is important. This study aims to implement and evaluate biophysical and psychosocial outcomes of a peer support program and to explore it's feasibility and sustainability in China
Interventions
BEHAVIORALpeer support
OTHERusual education lectures
Sponsors
Zhongda Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. type 2 diabetes 2. with voluntary participation and have signed the Patient Informed Consent Sheet 3. reside in stable places during the intervention period
Exclusion criteria
1. Patients with reduced life expectancy and unstable mood or major psychiatric conditions 2. suffering from cancer and have been receiving radiotherapy and/ or chemotherapy in the past half year 3. enrolling in other research program at present
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change from Baseline HbA1c at 6 months,12 months | baselline,6months,12months |
Secondary
| Measure | Time frame |
|---|---|
| Change from Baseline months BMI at 6 months,12 months | baseline,6 months,12months |
| Change from Baseline months blood liquids at 6 months,12 months | baseline,6 months,12months |
| Change from Baseline months blood glucose at 6 months,12 months | baseline,6 months,12months |
| Change from baseline in diabetes self-care activities scales at 6 months,12months | baseline,6 months,12months |
| Change from baseline in depression scales at 6 months,12months | baseline,6 months,12months |
| Change from baseline in medication adherence scales at 6 months,12months | baseline,6 months,12months |
| Change from Baseline blood pressure at 6 months,12 months | baseline,6 months,12months |
| Change from baseline in diabetes self-efficacy scales at 6 months,12months | baseline,6 months,12months |
| Change from baseline in diabetes knowledge scales at 6 months,12months | baseline,6 months, 12 months |
| Change from baseline in positive and negative affectivity at 6 months,12months | baseline, 6 months,12months |
| Change from baseline in events of hypoglycemia at 6 months,12months | baseline,6 months,12months |
| Change from baseline advanced glycation end products at 6 months,12months | baseline ,6 months,12months |
| cost | baseline,6 months,12 months |
| Change from baseline in quality of life scales at 6 months,12months | baseline,6 months,12months |
Countries
China
Contacts
Primary ContactBo Xie, MPH
Outcome results
None listed